Each individual entry is a single program reported by a single jurisdiction in a given fiscal year. Because we want to track the level and quality of disclosure as well as the content, the values below -- with the exception of program names -- are entered exactly as they are reported. See our user guide for more explanations.
| State: | Massachusetts |
| Effected Jurisdiction: | Massachusetts |
Jurisdiction type: | State |
| Fiscal year ending In: | 2021 |
| Program name: | Life Sciences Tax Incentive Program |
| Program purpose: | Technology (biotech) |
| Statutory authority: | multiple |
| Abating jurisdiction(s): | State of Massachusetts |
| Applicable taxes: | Corporate Excise Tax; Financial Institutions Excise Tax; Insurance Premium Tax; Personal Income Tax |
| Method of abatement: | Tax Credit |
| Provisions for recapture: | Certificate may be revoked |
| Gross revenue loss: | $19,500,000 |
| Reimbursement / offset: | $0 |
| Net revenue loss: | $19,500,000 |
| Type of loss: | Active |
| Additional notes on dislosure: | (none) |
| Document source: | https://www.macomptroller.org/annual-comprehensive-financial-reports/ |
